Review



fitc conjugated erythrina cristagalli eca  (Vector Laboratories)


Bioz Verified Symbol Vector Laboratories is a verified supplier
Bioz Manufacturer Symbol Vector Laboratories manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Vector Laboratories fitc conjugated erythrina cristagalli eca
    Fitc Conjugated Erythrina Cristagalli Eca, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 44 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/FL-1141-5/Fluorescein+labeled+Erythrina+Cristagalli+Lectin+(ECL%2C+ECA)/pm41417753-172-22-27
    Average 94 stars, based on 44 article reviews
    fitc conjugated erythrina cristagalli eca - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    Blocking Assay:

    Article Title: Siglec-engaging immunosuppressive sialoglycans are upregulated in prostate cancer and are targetable to suppress bone metastasis
    Article Snippet: .. After another PBS wash, cells were blocked with 1X Carbo-FreeTM Blocking Solution (1X CFB) (Vector Laboratories, SP-5040-125) for 1 hr at room temperature, before they were incubated overnight in the dark at 4 °C in 1:1000 Fluorescein-labelled Peanut Agglutinin (PNA) Lectin (Vector Laboratories, FL-1071), 1:1000 Fluorescein-labelled Erythrina Cristagalli Lectin (ECL, ECA) (Vector Laboratories, FL-1141-5), 1:1000 Fluorescein-labelled Concanavalin A (Con A) Lectin (Vector Laboratories, FL-1001-25) or 1:400 SureLight® 488-conjugated SiaFind Alpha 2,3-Specific Lectenz® (Lectenz Bio, SK2301F). .. Finally, following PBS washes, cells were stained with 1:1200 Hoechst Nucleic Acid Stain (Thermo Scientific, 62249) for 15 min at room temperature.

    Incubation:

    Article Title: Siglec-engaging immunosuppressive sialoglycans are upregulated in prostate cancer and are targetable to suppress bone metastasis
    Article Snippet: .. After another PBS wash, cells were blocked with 1X Carbo-FreeTM Blocking Solution (1X CFB) (Vector Laboratories, SP-5040-125) for 1 hr at room temperature, before they were incubated overnight in the dark at 4 °C in 1:1000 Fluorescein-labelled Peanut Agglutinin (PNA) Lectin (Vector Laboratories, FL-1071), 1:1000 Fluorescein-labelled Erythrina Cristagalli Lectin (ECL, ECA) (Vector Laboratories, FL-1141-5), 1:1000 Fluorescein-labelled Concanavalin A (Con A) Lectin (Vector Laboratories, FL-1001-25) or 1:400 SureLight® 488-conjugated SiaFind Alpha 2,3-Specific Lectenz® (Lectenz Bio, SK2301F). .. Finally, following PBS washes, cells were stained with 1:1200 Hoechst Nucleic Acid Stain (Thermo Scientific, 62249) for 15 min at room temperature.

    Article Title: Siglec-engaging immunosuppressive sialoglycans are upregulated in prostate cancer and are targetable to suppress bone metastasis
    Article Snippet: .. They were washed twice with 1X CFB before being resuspended in 100 μL of 1:2000 Fluorescein-labelled Peanut Agglutinin (PNA) Lectin (Vector Laboratories, FL-1071), 1:2000 Fluorescein-labelled Erythrina Cristagalli Lectin (ECL, ECA) (Vector Laboratories, FL-1141-5) or 1:400 SureLight® 488-conjugated SiaFind Alpha 2,3-Specific Lectenz® (Lectenz Bio, SK2301F) in 1X CFB and incubated for 30 min in the dark at 4 °C. ..

    Staining:

    Article Title: Age-related remodeling of the sialoglycans dampens murine CD8 + T cell function
    Article Snippet: Cells were stained with fixable aqua Live/Dead staining ( L34966 , Thermo Fisher Scientific), FcR block (Thermo Fisher Scientific), and surface marker antibodies in phosphate-buffered saline (PBS) containing 2 mM EDTA at 4°C for 20 min and analyzed with a five-laser LSR Fortessa X-20. .. Specifically, fluorophore-conjugated lectins, such as SNA (21500045-1, Bioworld; 1:200), ECL (FL-1141-5, Vector Laboratories, 1:200), and SLBR-N and SLBR-H [made in the Mahal laboratory as previously described ( )], were stained together with other surface marker antibodies. ..

    Article Title: Gne deletion in adult mice can cause thrombocytopenia, anemia, myopathy, bleeding, and death.
    Article Snippet: Platelets were stained and gated with CD41-BV421 (#133912; BioLegend, San Diego, CA). α−2,6- and α−2,3-linked sialic acid was detected using 20 μg/ mL Cy5-labeled Sambucus nigra lectin (SNA) (#CL-1305; Vector Laboratories, Newark, CA) or 20 μg/mL Cy5-labeled Maackia amurensis lectin II (MAL II) (#21511110-1; GlycoMatrix, Dublin, OH), respectively. .. Surface galactose was stained with 10 μg/mL fluorescein isothiocyanate (FITC)– conjugated Ricinus communis I (RCA-1) (#FL-1081-1; Vector Laboratories, Newark, CA), 10 μg/mL FITC-conjugated Erythrina cristagalli (ECA) (#FL-1141-5; Vector Laboratories, Newark, CA), or 10 μg/mL FITC-conjugated peanut agglutinin (PNA) (#FL-1071-5; Vector Laboratories, Newark, CA). .. Cells were stained for 30 min at room temperature, then diluted in Tyrode’s buffer without calcium before being acquired on a BD Fortessa flow cytometer (BD Life Sciences, Franklin Lakes, NJ), with at least 10,000 gated events recorded.

    Marker:

    Article Title: Age-related remodeling of the sialoglycans dampens murine CD8 + T cell function
    Article Snippet: Cells were stained with fixable aqua Live/Dead staining ( L34966 , Thermo Fisher Scientific), FcR block (Thermo Fisher Scientific), and surface marker antibodies in phosphate-buffered saline (PBS) containing 2 mM EDTA at 4°C for 20 min and analyzed with a five-laser LSR Fortessa X-20. .. Specifically, fluorophore-conjugated lectins, such as SNA (21500045-1, Bioworld; 1:200), ECL (FL-1141-5, Vector Laboratories, 1:200), and SLBR-N and SLBR-H [made in the Mahal laboratory as previously described ( )], were stained together with other surface marker antibodies. ..



    Similar Products

    94
    Vector Laboratories fitc conjugated erythrina cristagalli eca
    Fitc Conjugated Erythrina Cristagalli Eca, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/FL-1141-5/Fluorescein+labeled+Erythrina+Cristagalli+Lectin+(ECL%2C+ECA)/pm41417753-172-22-27
    Average 94 stars, based on 1 article reviews
    fitc conjugated erythrina cristagalli eca - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Vector Laboratories fluorescein labeled erythrina cristagalli lectin (ecl, eca)
    Fluorescein Labeled Erythrina Cristagalli Lectin (Ecl, Eca), supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/FL-1141-5/Fluorescein+labeled+Erythrina+Cristagalli+Lectin+(ECL%2C+ECA)/custom%40fl-1141%4010%2E1101%2F2025%2E11%2E12%2E687981
    Average 94 stars, based on 1 article reviews
    fluorescein labeled erythrina cristagalli lectin (ecl, eca) - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Vector Laboratories fluorescein labelled erythrina cristagalli lectin
    ( A ) Detection of α2-3 linked sialylated glycans in CWR22Rv1 cells using α2-3 Lectenz flow cytometry. CWR22Rv1 cells were treated with a range of concentrations of E-612 for 24 hours. CWR22Rv1 treated with 1500nM E-612 had reduced levels of α2-3 Lectenz binding indicating a reduction in α2-3 linked sialylation in these cells. Reduced levels of α2-3 linked sialylated glycans were also detected in cells treated with E-612 using α2-3 Lectenz immunofluorescence. ( B ) <t>Lectin</t> flow cytometry and lectin immunofluorescence assays show CWR22Rv1 cells treated with E-612 for 24 hours have increased levels of binding to PNA lectin (which recognises galactosyl residues uncovered by the removal of sialic acids). ( C ) Detection of α2-3 linked sialylated glycans in mouse RM1 prostate cancer cells using α2-3 Lectenz flow cytometry. RM1 cells were treated with a range of concentrations of E-612 for 24 hours. RM1 cells treated with 1500nM E-612 had reduced levels of α2-3 Lectenz binding indicating a reduction in α2-3 linked sialylation in these cells. Reduced levels of α2-3 linked sialylated glycans were also detected in cells treated with E-612 using α2-3 Lectenz immunofluorescence. ( D ) Lectin flow cytometry and lectin immunofluorescence assays show RM1 cells treated with E-612 for 24 hours have increased levels of binding to PNA lectin (which recognises galactosyl residues uncovered by the removal of sialic acids). ( E ) HYDRA-7 flow cytometry shows treatment with 1500nM E-612 significantly reduces the binding of HYDRA-7 reagent to CWR22Rv1 cells indicating that E-612 has removed the sialoglycan ligands for Siglec-7 from the cell surface (unpaired t test, p=0.0207) ( F ) HYDRA-9 flow cytometry shows treatment with 1500nM E-612 significantly reduces the binding of HYDRA-9 reagent to CWR22Rv1 cells indicating that E-612 has removed the sialoglycan ligands for Siglec-9 from the cell surface (unpaired t test, p=0.0058).
    Fluorescein Labelled Erythrina Cristagalli Lectin, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/FL-1141-5/Fluorescein+labeled+Erythrina+Cristagalli+Lectin+(ECL%2C+ECA)/bio_rxiv__2025__11__12__687981-182-24-30
    Average 94 stars, based on 1 article reviews
    fluorescein labelled erythrina cristagalli lectin - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Vector Laboratories ecl
    ( A and B ) Peripheral blood was collected from young (≤6 months, n = 7) and old (≥18 months, n = 5) mice followed <t>by</t> <t>SNA</t> flow cytometry staining for measuring α2,6-linked sialic acid modifications. B cells (B220 + ), CD4 + T cells (CD4 + ), CD8 + T cells (CD8 + ), monocytes (Ly6C + ), and neutrophils (Ly6G + ) were gated on the basis of their respective surface markers. One representative plot is shown in (A) (young, 1.5 months; and old, 25 months) and summarized in (B). ( C ) Biosynthetic pathways for sialic acid linkages. Lectin specificities are indicated in red. ( D ) Peripheral blood samples from young ( n = 4) and old ( n = 4) mice were analyzed by <t>ECL</t> using flow cytometry staining. ( E ) Peripheral blood samples from young ( n = 4) and old ( n = 13) mice were analyzed by SLBR-N using flow cytometry staining. ( F to H ) Peripheral blood was collected from young (≤6 months, n = 12), mid-aged (7 to 17 months, n = 8), and old (≥18 months, n = 23) mice followed by SNA flow cytometry staining. One representative plot of CD8 + T cells staining is shown in (F). The levels of α2,6-linked sialic acid were quantified by percent of SNA high cells in (G) and the mean fluorescence intensity (MFI) of SNA high cells were quantified in (H). All data are represented in box plots showing the quartiles of the data with whiskers showing the rest of the distribution. P values were calculated by two-tailed Student’s t test.
    Ecl, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/FL-1141-5/Fluorescein+labeled+Erythrina+Cristagalli+Lectin+(ECL%2C+ECA)/pmc12467053-138-9-11
    Average 94 stars, based on 1 article reviews
    ecl - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Vector Laboratories fluorescein labelled erythrina cristagalli lectin eca
    ( A and B ) Peripheral blood was collected from young (≤6 months, n = 7) and old (≥18 months, n = 5) mice followed <t>by</t> <t>SNA</t> flow cytometry staining for measuring α2,6-linked sialic acid modifications. B cells (B220 + ), CD4 + T cells (CD4 + ), CD8 + T cells (CD8 + ), monocytes (Ly6C + ), and neutrophils (Ly6G + ) were gated on the basis of their respective surface markers. One representative plot is shown in (A) (young, 1.5 months; and old, 25 months) and summarized in (B). ( C ) Biosynthetic pathways for sialic acid linkages. Lectin specificities are indicated in red. ( D ) Peripheral blood samples from young ( n = 4) and old ( n = 4) mice were analyzed by <t>ECL</t> using flow cytometry staining. ( E ) Peripheral blood samples from young ( n = 4) and old ( n = 13) mice were analyzed by SLBR-N using flow cytometry staining. ( F to H ) Peripheral blood was collected from young (≤6 months, n = 12), mid-aged (7 to 17 months, n = 8), and old (≥18 months, n = 23) mice followed by SNA flow cytometry staining. One representative plot of CD8 + T cells staining is shown in (F). The levels of α2,6-linked sialic acid were quantified by percent of SNA high cells in (G) and the mean fluorescence intensity (MFI) of SNA high cells were quantified in (H). All data are represented in box plots showing the quartiles of the data with whiskers showing the rest of the distribution. P values were calculated by two-tailed Student’s t test.
    Fluorescein Labelled Erythrina Cristagalli Lectin Eca, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/FL-1141-5/Fluorescein+labeled+Erythrina+Cristagalli+Lectin+(ECL%2C+ECA)/pmc12383273__sciadv%2Eady3554_sm-235-20-27
    Average 94 stars, based on 1 article reviews
    fluorescein labelled erythrina cristagalli lectin eca - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Vector Laboratories fitc ecl
    xCEP290-depletion produced edema and dilated pronephric tubule in Xenopus embryo . A , the edema formation observed in x CEP290 morphant. Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (10 ng), lower left panel : xCEP290-MO (20 ng), and lower right panel : xCEP290-MO (40 ng). A typical edema in each panel is indicated by a white arrow . The scale bar represents 1 mm. B , the percentage of embryos with edema in examined embryos in ( A ). Each ‘n’ indicates the total number of embryos from three independent experiments. C , the schematic showing Xenopus pronephric tubular segmentated patterns . Each color represents coelomic cavity ( flesh color ), glomerulus/glomus ( red ), proximal tubule ( yellow green ), distal tubule ( purple ) and collecting tubule ( blue ). Proximal and distal pronephric tubules are stained by <t>FITC-conjugated</t> Erythrina crista-galli lectin <t>(FITC-ECL:</t> green ) at stage 37. Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (10 ng), lower left panel : xCEP290-MO (20 ng), and lower right panel : xCEP290-MO (40 ng). A typical expanded inner diameter of pronephric tubule is indicated by a white arrow in the lower right panel . The scale bar represents 50 μm. D , quantification of inner diameter in pronephric tubule of examined embryo in ( C ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗: p < 0.0001. E , edema formation in xCEP290 morphant with or without co-injection of hCEP290 mRNA. Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (40 ng), lower left panel : control-MO (40 ng) with hCEP290 mRNA (500 pg), and lower right panel : xCEP290-MO (40 ng) with hCEP290 mRNA (500 pg). Edemas are indicated by white arrows in the upper right panel . The scale bar represents 1 mm. F , the percentage of embryos with edema in examined embryos in ( E ). Each ‘n’ indicates the total number of embryos from three independent experiments. G , pronephric tubule was visualized using FITC-ECL staining ( green ). Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (40 ng), lower left panel : control-MO (40 ng) with hCEP290 mRNA (500 pg), and lower right panel : xCEP290-MO (40 ng) with hCEP290 mRNA (500 pg). The scale bar represents 50 μm. H , quantification of inner diameter in pronephric tubule of examined embryo in ( G ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗: p < 0.0001.
    Fitc Ecl, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/FL-1141-5/Fluorescein+labeled+Erythrina+Cristagalli+Lectin+(ECL%2C+ECA)/pmc12302719-272-40-41
    Average 94 stars, based on 1 article reviews
    fitc ecl - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Vector Laboratories crist agall i lectin
    xCEP290-depletion produced edema and dilated pronephric tubule in Xenopus embryo . A , the edema formation observed in x CEP290 morphant. Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (10 ng), lower left panel : xCEP290-MO (20 ng), and lower right panel : xCEP290-MO (40 ng). A typical edema in each panel is indicated by a white arrow . The scale bar represents 1 mm. B , the percentage of embryos with edema in examined embryos in ( A ). Each ‘n’ indicates the total number of embryos from three independent experiments. C , the schematic showing Xenopus pronephric tubular segmentated patterns . Each color represents coelomic cavity ( flesh color ), glomerulus/glomus ( red ), proximal tubule ( yellow green ), distal tubule ( purple ) and collecting tubule ( blue ). Proximal and distal pronephric tubules are stained by FITC-conjugated Erythrina crista-galli <t>lectin</t> (FITC-ECL: green ) at stage 37. Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (10 ng), lower left panel : xCEP290-MO (20 ng), and lower right panel : xCEP290-MO (40 ng). A typical expanded inner diameter of pronephric tubule is indicated by a white arrow in the lower right panel . The scale bar represents 50 μm. D , quantification of inner diameter in pronephric tubule of examined embryo in ( C ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗: p < 0.0001. E , edema formation in xCEP290 morphant with or without co-injection of hCEP290 mRNA. Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (40 ng), lower left panel : control-MO (40 ng) with hCEP290 mRNA (500 pg), and lower right panel : xCEP290-MO (40 ng) with hCEP290 mRNA (500 pg). Edemas are indicated by white arrows in the upper right panel . The scale bar represents 1 mm. F , the percentage of embryos with edema in examined embryos in ( E ). Each ‘n’ indicates the total number of embryos from three independent experiments. G , pronephric tubule was visualized using FITC-ECL staining ( green ). Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (40 ng), lower left panel : control-MO (40 ng) with hCEP290 mRNA (500 pg), and lower right panel : xCEP290-MO (40 ng) with hCEP290 mRNA (500 pg). The scale bar represents 50 μm. H , quantification of inner diameter in pronephric tubule of examined embryo in ( G ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗: p < 0.0001.
    Crist Agall I Lectin, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/FL-1141-5/Fluorescein+labeled+Erythrina+Cristagalli+Lectin+(ECL%2C+ECA)/pmc12302719-260-35-39
    Average 94 stars, based on 1 article reviews
    crist agall i lectin - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Detection of α2-3 linked sialylated glycans in CWR22Rv1 cells using α2-3 Lectenz flow cytometry. CWR22Rv1 cells were treated with a range of concentrations of E-612 for 24 hours. CWR22Rv1 treated with 1500nM E-612 had reduced levels of α2-3 Lectenz binding indicating a reduction in α2-3 linked sialylation in these cells. Reduced levels of α2-3 linked sialylated glycans were also detected in cells treated with E-612 using α2-3 Lectenz immunofluorescence. ( B ) Lectin flow cytometry and lectin immunofluorescence assays show CWR22Rv1 cells treated with E-612 for 24 hours have increased levels of binding to PNA lectin (which recognises galactosyl residues uncovered by the removal of sialic acids). ( C ) Detection of α2-3 linked sialylated glycans in mouse RM1 prostate cancer cells using α2-3 Lectenz flow cytometry. RM1 cells were treated with a range of concentrations of E-612 for 24 hours. RM1 cells treated with 1500nM E-612 had reduced levels of α2-3 Lectenz binding indicating a reduction in α2-3 linked sialylation in these cells. Reduced levels of α2-3 linked sialylated glycans were also detected in cells treated with E-612 using α2-3 Lectenz immunofluorescence. ( D ) Lectin flow cytometry and lectin immunofluorescence assays show RM1 cells treated with E-612 for 24 hours have increased levels of binding to PNA lectin (which recognises galactosyl residues uncovered by the removal of sialic acids). ( E ) HYDRA-7 flow cytometry shows treatment with 1500nM E-612 significantly reduces the binding of HYDRA-7 reagent to CWR22Rv1 cells indicating that E-612 has removed the sialoglycan ligands for Siglec-7 from the cell surface (unpaired t test, p=0.0207) ( F ) HYDRA-9 flow cytometry shows treatment with 1500nM E-612 significantly reduces the binding of HYDRA-9 reagent to CWR22Rv1 cells indicating that E-612 has removed the sialoglycan ligands for Siglec-9 from the cell surface (unpaired t test, p=0.0058).

    Journal: bioRxiv

    Article Title: Siglec-engaging immunosuppressive sialoglycans are upregulated in prostate cancer and are targetable to suppress bone metastasis

    doi: 10.1101/2025.11.12.687981

    Figure Lengend Snippet: ( A ) Detection of α2-3 linked sialylated glycans in CWR22Rv1 cells using α2-3 Lectenz flow cytometry. CWR22Rv1 cells were treated with a range of concentrations of E-612 for 24 hours. CWR22Rv1 treated with 1500nM E-612 had reduced levels of α2-3 Lectenz binding indicating a reduction in α2-3 linked sialylation in these cells. Reduced levels of α2-3 linked sialylated glycans were also detected in cells treated with E-612 using α2-3 Lectenz immunofluorescence. ( B ) Lectin flow cytometry and lectin immunofluorescence assays show CWR22Rv1 cells treated with E-612 for 24 hours have increased levels of binding to PNA lectin (which recognises galactosyl residues uncovered by the removal of sialic acids). ( C ) Detection of α2-3 linked sialylated glycans in mouse RM1 prostate cancer cells using α2-3 Lectenz flow cytometry. RM1 cells were treated with a range of concentrations of E-612 for 24 hours. RM1 cells treated with 1500nM E-612 had reduced levels of α2-3 Lectenz binding indicating a reduction in α2-3 linked sialylation in these cells. Reduced levels of α2-3 linked sialylated glycans were also detected in cells treated with E-612 using α2-3 Lectenz immunofluorescence. ( D ) Lectin flow cytometry and lectin immunofluorescence assays show RM1 cells treated with E-612 for 24 hours have increased levels of binding to PNA lectin (which recognises galactosyl residues uncovered by the removal of sialic acids). ( E ) HYDRA-7 flow cytometry shows treatment with 1500nM E-612 significantly reduces the binding of HYDRA-7 reagent to CWR22Rv1 cells indicating that E-612 has removed the sialoglycan ligands for Siglec-7 from the cell surface (unpaired t test, p=0.0207) ( F ) HYDRA-9 flow cytometry shows treatment with 1500nM E-612 significantly reduces the binding of HYDRA-9 reagent to CWR22Rv1 cells indicating that E-612 has removed the sialoglycan ligands for Siglec-9 from the cell surface (unpaired t test, p=0.0058).

    Article Snippet: They were washed twice with 1X CFB before being resuspended in 100 μL of 1:2000 Fluorescein-labelled Peanut Agglutinin (PNA) Lectin (Vector Laboratories, FL-1071), 1:2000 Fluorescein-labelled Erythrina Cristagalli Lectin (ECL, ECA) (Vector Laboratories, FL-1141-5) or 1:400 SureLight® 488-conjugated SiaFind Alpha 2,3-Specific Lectenz® (Lectenz Bio, SK2301F) in 1X CFB and incubated for 30 min in the dark at 4 °C.

    Techniques: Flow Cytometry, Binding Assay, Immunofluorescence

    ( A ) Dual immunofluorescence analysis of Siglec-E and CD14 (a myeloid marker) in PC3 prostate cancer tumours growing in mouse tibias. Siglec-E is co-localised with CD14 confirming its expression by myeloid cells within the murine prostate cancer TIME. Scale bar is 20□µm. ( B ) Using an RM1 intra-cardiac injection metastasis model, we investigated if therapeutic desialylation by E-612 can increase survival times of mice with metastatic prostate cancer. ( C ) Twice weekly dosing with 10mg/kg E-612 via intra-peritoneal injection prolongs the median survival rates of mice with metastatic prostate cancer by 53%. ( D ) Using an RM1 intra-caudal injection bone metastasis model we tested if E-612 mediated tumour desialylation can suppress the growth of bone metastatic prostate tumours. ( E ) Systemic treatment with E-612 (twice weekly dosing with 10mg/kg E-612 via intra-peritoneal injection) significantly reduces prostate cancer bone metastasis tumour burden (unpaired t test, p=0.0456). ( F ) PNA lectin flow cytometry analysis of white blood cells from mice treated with E-612. Systemic E-612 therapy significantly increases the levels PNA lectin binding to circulating immune cells (PNA lectin recognises galactosyl residues that are uncovered by the removal of sialic acids ) (Welch’s t test, p<0.0001).

    Journal: bioRxiv

    Article Title: Siglec-engaging immunosuppressive sialoglycans are upregulated in prostate cancer and are targetable to suppress bone metastasis

    doi: 10.1101/2025.11.12.687981

    Figure Lengend Snippet: ( A ) Dual immunofluorescence analysis of Siglec-E and CD14 (a myeloid marker) in PC3 prostate cancer tumours growing in mouse tibias. Siglec-E is co-localised with CD14 confirming its expression by myeloid cells within the murine prostate cancer TIME. Scale bar is 20□µm. ( B ) Using an RM1 intra-cardiac injection metastasis model, we investigated if therapeutic desialylation by E-612 can increase survival times of mice with metastatic prostate cancer. ( C ) Twice weekly dosing with 10mg/kg E-612 via intra-peritoneal injection prolongs the median survival rates of mice with metastatic prostate cancer by 53%. ( D ) Using an RM1 intra-caudal injection bone metastasis model we tested if E-612 mediated tumour desialylation can suppress the growth of bone metastatic prostate tumours. ( E ) Systemic treatment with E-612 (twice weekly dosing with 10mg/kg E-612 via intra-peritoneal injection) significantly reduces prostate cancer bone metastasis tumour burden (unpaired t test, p=0.0456). ( F ) PNA lectin flow cytometry analysis of white blood cells from mice treated with E-612. Systemic E-612 therapy significantly increases the levels PNA lectin binding to circulating immune cells (PNA lectin recognises galactosyl residues that are uncovered by the removal of sialic acids ) (Welch’s t test, p<0.0001).

    Article Snippet: They were washed twice with 1X CFB before being resuspended in 100 μL of 1:2000 Fluorescein-labelled Peanut Agglutinin (PNA) Lectin (Vector Laboratories, FL-1071), 1:2000 Fluorescein-labelled Erythrina Cristagalli Lectin (ECL, ECA) (Vector Laboratories, FL-1141-5) or 1:400 SureLight® 488-conjugated SiaFind Alpha 2,3-Specific Lectenz® (Lectenz Bio, SK2301F) in 1X CFB and incubated for 30 min in the dark at 4 °C.

    Techniques: Immunofluorescence, Marker, Expressing, Injection, Flow Cytometry, Binding Assay

    ( A and B ) Peripheral blood was collected from young (≤6 months, n = 7) and old (≥18 months, n = 5) mice followed by SNA flow cytometry staining for measuring α2,6-linked sialic acid modifications. B cells (B220 + ), CD4 + T cells (CD4 + ), CD8 + T cells (CD8 + ), monocytes (Ly6C + ), and neutrophils (Ly6G + ) were gated on the basis of their respective surface markers. One representative plot is shown in (A) (young, 1.5 months; and old, 25 months) and summarized in (B). ( C ) Biosynthetic pathways for sialic acid linkages. Lectin specificities are indicated in red. ( D ) Peripheral blood samples from young ( n = 4) and old ( n = 4) mice were analyzed by ECL using flow cytometry staining. ( E ) Peripheral blood samples from young ( n = 4) and old ( n = 13) mice were analyzed by SLBR-N using flow cytometry staining. ( F to H ) Peripheral blood was collected from young (≤6 months, n = 12), mid-aged (7 to 17 months, n = 8), and old (≥18 months, n = 23) mice followed by SNA flow cytometry staining. One representative plot of CD8 + T cells staining is shown in (F). The levels of α2,6-linked sialic acid were quantified by percent of SNA high cells in (G) and the mean fluorescence intensity (MFI) of SNA high cells were quantified in (H). All data are represented in box plots showing the quartiles of the data with whiskers showing the rest of the distribution. P values were calculated by two-tailed Student’s t test.

    Journal: Science Advances

    Article Title: Age-related remodeling of the sialoglycans dampens murine CD8 + T cell function

    doi: 10.1126/sciadv.adw6755

    Figure Lengend Snippet: ( A and B ) Peripheral blood was collected from young (≤6 months, n = 7) and old (≥18 months, n = 5) mice followed by SNA flow cytometry staining for measuring α2,6-linked sialic acid modifications. B cells (B220 + ), CD4 + T cells (CD4 + ), CD8 + T cells (CD8 + ), monocytes (Ly6C + ), and neutrophils (Ly6G + ) were gated on the basis of their respective surface markers. One representative plot is shown in (A) (young, 1.5 months; and old, 25 months) and summarized in (B). ( C ) Biosynthetic pathways for sialic acid linkages. Lectin specificities are indicated in red. ( D ) Peripheral blood samples from young ( n = 4) and old ( n = 4) mice were analyzed by ECL using flow cytometry staining. ( E ) Peripheral blood samples from young ( n = 4) and old ( n = 13) mice were analyzed by SLBR-N using flow cytometry staining. ( F to H ) Peripheral blood was collected from young (≤6 months, n = 12), mid-aged (7 to 17 months, n = 8), and old (≥18 months, n = 23) mice followed by SNA flow cytometry staining. One representative plot of CD8 + T cells staining is shown in (F). The levels of α2,6-linked sialic acid were quantified by percent of SNA high cells in (G) and the mean fluorescence intensity (MFI) of SNA high cells were quantified in (H). All data are represented in box plots showing the quartiles of the data with whiskers showing the rest of the distribution. P values were calculated by two-tailed Student’s t test.

    Article Snippet: Specifically, fluorophore-conjugated lectins, such as SNA (21500045-1, Bioworld; 1:200), ECL (FL-1141-5, Vector Laboratories, 1:200), and SLBR-N and SLBR-H [made in the Mahal laboratory as previously described ( )], were stained together with other surface marker antibodies.

    Techniques: Flow Cytometry, Staining, Fluorescence, Two Tailed Test

    xCEP290-depletion produced edema and dilated pronephric tubule in Xenopus embryo . A , the edema formation observed in x CEP290 morphant. Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (10 ng), lower left panel : xCEP290-MO (20 ng), and lower right panel : xCEP290-MO (40 ng). A typical edema in each panel is indicated by a white arrow . The scale bar represents 1 mm. B , the percentage of embryos with edema in examined embryos in ( A ). Each ‘n’ indicates the total number of embryos from three independent experiments. C , the schematic showing Xenopus pronephric tubular segmentated patterns . Each color represents coelomic cavity ( flesh color ), glomerulus/glomus ( red ), proximal tubule ( yellow green ), distal tubule ( purple ) and collecting tubule ( blue ). Proximal and distal pronephric tubules are stained by FITC-conjugated Erythrina crista-galli lectin (FITC-ECL: green ) at stage 37. Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (10 ng), lower left panel : xCEP290-MO (20 ng), and lower right panel : xCEP290-MO (40 ng). A typical expanded inner diameter of pronephric tubule is indicated by a white arrow in the lower right panel . The scale bar represents 50 μm. D , quantification of inner diameter in pronephric tubule of examined embryo in ( C ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗: p < 0.0001. E , edema formation in xCEP290 morphant with or without co-injection of hCEP290 mRNA. Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (40 ng), lower left panel : control-MO (40 ng) with hCEP290 mRNA (500 pg), and lower right panel : xCEP290-MO (40 ng) with hCEP290 mRNA (500 pg). Edemas are indicated by white arrows in the upper right panel . The scale bar represents 1 mm. F , the percentage of embryos with edema in examined embryos in ( E ). Each ‘n’ indicates the total number of embryos from three independent experiments. G , pronephric tubule was visualized using FITC-ECL staining ( green ). Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (40 ng), lower left panel : control-MO (40 ng) with hCEP290 mRNA (500 pg), and lower right panel : xCEP290-MO (40 ng) with hCEP290 mRNA (500 pg). The scale bar represents 50 μm. H , quantification of inner diameter in pronephric tubule of examined embryo in ( G ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗: p < 0.0001.

    Journal: The Journal of Biological Chemistry

    Article Title: Aberrant activation of IL-6/JAK/STAT3/FOSL1 signaling induces renal abnormalities in a Xenopus model of Joubert syndrome-related disorders

    doi: 10.1016/j.jbc.2025.110413

    Figure Lengend Snippet: xCEP290-depletion produced edema and dilated pronephric tubule in Xenopus embryo . A , the edema formation observed in x CEP290 morphant. Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (10 ng), lower left panel : xCEP290-MO (20 ng), and lower right panel : xCEP290-MO (40 ng). A typical edema in each panel is indicated by a white arrow . The scale bar represents 1 mm. B , the percentage of embryos with edema in examined embryos in ( A ). Each ‘n’ indicates the total number of embryos from three independent experiments. C , the schematic showing Xenopus pronephric tubular segmentated patterns . Each color represents coelomic cavity ( flesh color ), glomerulus/glomus ( red ), proximal tubule ( yellow green ), distal tubule ( purple ) and collecting tubule ( blue ). Proximal and distal pronephric tubules are stained by FITC-conjugated Erythrina crista-galli lectin (FITC-ECL: green ) at stage 37. Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (10 ng), lower left panel : xCEP290-MO (20 ng), and lower right panel : xCEP290-MO (40 ng). A typical expanded inner diameter of pronephric tubule is indicated by a white arrow in the lower right panel . The scale bar represents 50 μm. D , quantification of inner diameter in pronephric tubule of examined embryo in ( C ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗: p < 0.0001. E , edema formation in xCEP290 morphant with or without co-injection of hCEP290 mRNA. Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (40 ng), lower left panel : control-MO (40 ng) with hCEP290 mRNA (500 pg), and lower right panel : xCEP290-MO (40 ng) with hCEP290 mRNA (500 pg). Edemas are indicated by white arrows in the upper right panel . The scale bar represents 1 mm. F , the percentage of embryos with edema in examined embryos in ( E ). Each ‘n’ indicates the total number of embryos from three independent experiments. G , pronephric tubule was visualized using FITC-ECL staining ( green ). Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (40 ng), lower left panel : control-MO (40 ng) with hCEP290 mRNA (500 pg), and lower right panel : xCEP290-MO (40 ng) with hCEP290 mRNA (500 pg). The scale bar represents 50 μm. H , quantification of inner diameter in pronephric tubule of examined embryo in ( G ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗: p < 0.0001.

    Article Snippet: Following three washes in PBT, embryos were incubated with 10% goat serum in PBT at room temperature for 1 h. Then incubated at 4 o C overnight with the following primary antibodies: mouse acetylated- α -tubulin antibody (Sigma-Aldrich, T6793, 1/100), FITC-ECL (Vector Laboratories, FL-1141, 1/100) and rabbit anti-phosphorylated-xSTAT3 (p-STAT3: Tyr705) (Cell Signaling, 9145, 1/200).

    Techniques: Produced, Control, Staining, Injection

    The treatment of tolvaptan rescued renal phenotype in xCEP290 morphant . A , schematic showing time scale of the tolvaptan treatment. control-MO (40 ng) and xCEP290-MO (40 ng) were injected into Xenopus embryo at stage 2 to 4; tolvaptan (50 μM) was treated from stage 10, followed by pronephric tubule staining at stage 37 embryo and observation of phenotype until stage 45. B , edema formation in xCEP290 morphant with the tolvaptan treatment. Upper left and right panels : control-MO (40 ng) and xCEP290-MO (40 ng) with DMSO treatment, respectively, lower left and right panels : xCEP290-MO (40 ng) with the tolvaptan treatment of 20 μM and 50 μM. Edema are indicated by white arrows in the upper right panel and lower panels . The scale bar represents 1 mm. C , the percentage of embryos with edema in the examined embryos in (B). Each ‘n’ indicates the total number of embryos from three independent experiments. D , pronephric tubule was visualized using FITC-ECL staining ( green ). Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (40 ng) with DMSO treatment, lower left panel : xCEP290-MO (40 ng) with the tolvaptan treatment (20 μM), lower right panel : xCEP290-MO (40 ng) with the tolvaptan treatment (50 μM). Improved pronephric tubule is indicated by a white arrow in the lower panels , respectively. The scale bar represents 50 μm . E , quantification of pronephric tubular inner diameter in examined embryos in ( D ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗: p < 0.0001.

    Journal: The Journal of Biological Chemistry

    Article Title: Aberrant activation of IL-6/JAK/STAT3/FOSL1 signaling induces renal abnormalities in a Xenopus model of Joubert syndrome-related disorders

    doi: 10.1016/j.jbc.2025.110413

    Figure Lengend Snippet: The treatment of tolvaptan rescued renal phenotype in xCEP290 morphant . A , schematic showing time scale of the tolvaptan treatment. control-MO (40 ng) and xCEP290-MO (40 ng) were injected into Xenopus embryo at stage 2 to 4; tolvaptan (50 μM) was treated from stage 10, followed by pronephric tubule staining at stage 37 embryo and observation of phenotype until stage 45. B , edema formation in xCEP290 morphant with the tolvaptan treatment. Upper left and right panels : control-MO (40 ng) and xCEP290-MO (40 ng) with DMSO treatment, respectively, lower left and right panels : xCEP290-MO (40 ng) with the tolvaptan treatment of 20 μM and 50 μM. Edema are indicated by white arrows in the upper right panel and lower panels . The scale bar represents 1 mm. C , the percentage of embryos with edema in the examined embryos in (B). Each ‘n’ indicates the total number of embryos from three independent experiments. D , pronephric tubule was visualized using FITC-ECL staining ( green ). Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (40 ng) with DMSO treatment, lower left panel : xCEP290-MO (40 ng) with the tolvaptan treatment (20 μM), lower right panel : xCEP290-MO (40 ng) with the tolvaptan treatment (50 μM). Improved pronephric tubule is indicated by a white arrow in the lower panels , respectively. The scale bar represents 50 μm . E , quantification of pronephric tubular inner diameter in examined embryos in ( D ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗: p < 0.0001.

    Article Snippet: Following three washes in PBT, embryos were incubated with 10% goat serum in PBT at room temperature for 1 h. Then incubated at 4 o C overnight with the following primary antibodies: mouse acetylated- α -tubulin antibody (Sigma-Aldrich, T6793, 1/100), FITC-ECL (Vector Laboratories, FL-1141, 1/100) and rabbit anti-phosphorylated-xSTAT3 (p-STAT3: Tyr705) (Cell Signaling, 9145, 1/200).

    Techniques: Control, Injection, Staining

    Inhibition of the JAK activity rescued renal phenotype of xCEP290 morphant . A , the schematic showing time scale of the ruxolitinib treatment. control-MO (40 ng) and xCEP290-MO (40 ng) were injected in Xenopus embryo at stage 2 to 4; ruxolitinib (1 μM) was treated from stage 10, followed by pronephric tubule staining at stage 37 embryo and observation of phenotype until stage 45. B , edema formation in xCEP290 morphant with or without the ruxolitinib treatment. Upper panel : xCEP290-MO (40 ng) with DMSO treatment, lower panel : xCEP290-MO (40 ng) with the ruxolitinib treatment of 1 μM. Edemas were indicated by white arrows in the upper panel . The scale bar represents 1 mm. C , the percentage of embryos with edema in examined embryos in (B). Each ‘n’ indicates the total number of embryos from three independent experiments. D , pronephric tubule was visualized using FITC-ECL staining ( green ). left panel : control-MO (40 ng), middle panel : xCEP290-MO (40 ng) with DMSO treatment, right panel : xCEP290-MO (40 ng) with the ruxolitinib treatment of 1 μM. The scale bar represents 50 μm. E , quantification of pronephric tubular inner diameter in examined embryos in ( E ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗: p < 0.0001. F , the number of p-STAT3 positive ( red ) pronephric tubular epithelial cells was increased in xCEP290 morphant kidney. Pronephric tubule and nucleus were visualized using FITC-ECL staining ( green ) and DAPI staining ( cyan ), respectively. The scale bar represents 20 μm. G , the percentage of p-STAT3 positive pronephric tubular epithelial cells in examined embryos in ( F ). Each ‘n’ indicates the total number of pronephric tubular epithelial cells from three independent experiments.

    Journal: The Journal of Biological Chemistry

    Article Title: Aberrant activation of IL-6/JAK/STAT3/FOSL1 signaling induces renal abnormalities in a Xenopus model of Joubert syndrome-related disorders

    doi: 10.1016/j.jbc.2025.110413

    Figure Lengend Snippet: Inhibition of the JAK activity rescued renal phenotype of xCEP290 morphant . A , the schematic showing time scale of the ruxolitinib treatment. control-MO (40 ng) and xCEP290-MO (40 ng) were injected in Xenopus embryo at stage 2 to 4; ruxolitinib (1 μM) was treated from stage 10, followed by pronephric tubule staining at stage 37 embryo and observation of phenotype until stage 45. B , edema formation in xCEP290 morphant with or without the ruxolitinib treatment. Upper panel : xCEP290-MO (40 ng) with DMSO treatment, lower panel : xCEP290-MO (40 ng) with the ruxolitinib treatment of 1 μM. Edemas were indicated by white arrows in the upper panel . The scale bar represents 1 mm. C , the percentage of embryos with edema in examined embryos in (B). Each ‘n’ indicates the total number of embryos from three independent experiments. D , pronephric tubule was visualized using FITC-ECL staining ( green ). left panel : control-MO (40 ng), middle panel : xCEP290-MO (40 ng) with DMSO treatment, right panel : xCEP290-MO (40 ng) with the ruxolitinib treatment of 1 μM. The scale bar represents 50 μm. E , quantification of pronephric tubular inner diameter in examined embryos in ( E ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗: p < 0.0001. F , the number of p-STAT3 positive ( red ) pronephric tubular epithelial cells was increased in xCEP290 morphant kidney. Pronephric tubule and nucleus were visualized using FITC-ECL staining ( green ) and DAPI staining ( cyan ), respectively. The scale bar represents 20 μm. G , the percentage of p-STAT3 positive pronephric tubular epithelial cells in examined embryos in ( F ). Each ‘n’ indicates the total number of pronephric tubular epithelial cells from three independent experiments.

    Article Snippet: Following three washes in PBT, embryos were incubated with 10% goat serum in PBT at room temperature for 1 h. Then incubated at 4 o C overnight with the following primary antibodies: mouse acetylated- α -tubulin antibody (Sigma-Aldrich, T6793, 1/100), FITC-ECL (Vector Laboratories, FL-1141, 1/100) and rabbit anti-phosphorylated-xSTAT3 (p-STAT3: Tyr705) (Cell Signaling, 9145, 1/200).

    Techniques: Inhibition, Activity Assay, Control, Injection, Staining

    Transcription factor FOSL1 induced renal phenotype of xCEP290 morphant . A , Volcano plot between xCEP290-depleted kidneys and control kidneys in RNA-seq analysis. xFOSL1 and xFOSL2 genes are shown. B , experimental design of RT-qPCR. control-MO and xCEP290-MO (40 ng) were injected at stage 2 to 4; DMSO and ruxolitinib (1 μM) was treated from stage 10, followed by kidney dissection at stage 37. The dissected kidneys were pooled for RT-qPCR. C , xFOSL1 . L gene expression was examined by RT-qPCR for each group in ( B ) from 5 independent experiments. ∗: p < 0.05, ∗∗: p < 0.01. D , experimental strategy with xFOSL1-GR protein. Upon binding with DEX, xFOSL1-GR protein translocates from cytoplasm to nucleus, and activates the transcription of xFOSL1 target genes. E , edema formation observed in xFOSL1-GR expressed Xenopus embryo with the DEX treatment. Upper left panel : no injection, lower left panel : wild type xFOSL1 mRNA (500 pg), upper right panel : xFOSL1-GR mRNA (1 ng), and lower right panel : xFOSL1-GR mRNA (1 ng) with the DEX treatment (200 μM). Edemas are indicated by white arrows in the lower right panel . The scale bar represents 1 mm. F , the percentage of embryos with edema in examined embryos in ( E ). Each ‘n’ indicates the total number of embryos from three independent experiments. G , pronephric tubule was visualized using FITC-ECL staining (green). Upper left panel : no injection, lower left panel: xFOSL1 mRNA (500 pg), upper right panel : xFOSL1-GR mRNA (1 ng), and lower right panel : xFOSL1-GR mRNA (1 ng) with the DEX treatment. The scale bar represents 50 μm. H , quantification of pronephric tubular inner diameter in examined embryos in ( G ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗: p < 0.0001. I , the observation of the edema in EnR-xFOSL1-GR mRNA co-injected xCEP290 morphant with or without the DEX treatment. Upper left panel : control-MO with the DEX treatment, lower left panel : xCEP290-MO with the DEX treatment, upper middle panel : xCEP290-MO with EnR-xFOSL1-GR mRNA (100 pg), and lower middle panel : xCEP290-MO with EnR-xFOSL1-GR mRNA (100 pg) and the DEX treatment. Enlarged images from the upper and lower middle panels are also shown. Edemas are indicated by white arrows . The scale bar represents 1 mm. J , the percentage of embryos with edema in examined embryos in ( I ). Each ‘n’ indicates the total number of embryos from three independent experiments. K , pronephric tubule was visualized by FITC-ECL staining ( green ). Upper left panel : control-MO with the DEX treatment, lower left panel : xCEP290-MO with the DEX treatment, upper right panel : xCEP290-MO with EnR-xFOSL1-GR mRNA (100 pg), and lower right panel : xCEP290-MO with EnR-xFOSL1-GR mRNA (100 pg) with the DEX treatment. The scale bar represents 50 μm. L , quantification of pronephric tubular inner diameter of in examined embryos in ( K ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗ indicates p < 0.0001. M , the expression level of xMMP1 gene induced by overexpression of xFOSL1 in kidney by RT-qPCR. Expressions of genes were normalized with xODC1 gene expression, and expressions in control groups were set as 1. Each data point represents the mean ± STDEV of three independent experiments were performed. ∗: p < 0.05.

    Journal: The Journal of Biological Chemistry

    Article Title: Aberrant activation of IL-6/JAK/STAT3/FOSL1 signaling induces renal abnormalities in a Xenopus model of Joubert syndrome-related disorders

    doi: 10.1016/j.jbc.2025.110413

    Figure Lengend Snippet: Transcription factor FOSL1 induced renal phenotype of xCEP290 morphant . A , Volcano plot between xCEP290-depleted kidneys and control kidneys in RNA-seq analysis. xFOSL1 and xFOSL2 genes are shown. B , experimental design of RT-qPCR. control-MO and xCEP290-MO (40 ng) were injected at stage 2 to 4; DMSO and ruxolitinib (1 μM) was treated from stage 10, followed by kidney dissection at stage 37. The dissected kidneys were pooled for RT-qPCR. C , xFOSL1 . L gene expression was examined by RT-qPCR for each group in ( B ) from 5 independent experiments. ∗: p < 0.05, ∗∗: p < 0.01. D , experimental strategy with xFOSL1-GR protein. Upon binding with DEX, xFOSL1-GR protein translocates from cytoplasm to nucleus, and activates the transcription of xFOSL1 target genes. E , edema formation observed in xFOSL1-GR expressed Xenopus embryo with the DEX treatment. Upper left panel : no injection, lower left panel : wild type xFOSL1 mRNA (500 pg), upper right panel : xFOSL1-GR mRNA (1 ng), and lower right panel : xFOSL1-GR mRNA (1 ng) with the DEX treatment (200 μM). Edemas are indicated by white arrows in the lower right panel . The scale bar represents 1 mm. F , the percentage of embryos with edema in examined embryos in ( E ). Each ‘n’ indicates the total number of embryos from three independent experiments. G , pronephric tubule was visualized using FITC-ECL staining (green). Upper left panel : no injection, lower left panel: xFOSL1 mRNA (500 pg), upper right panel : xFOSL1-GR mRNA (1 ng), and lower right panel : xFOSL1-GR mRNA (1 ng) with the DEX treatment. The scale bar represents 50 μm. H , quantification of pronephric tubular inner diameter in examined embryos in ( G ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗: p < 0.0001. I , the observation of the edema in EnR-xFOSL1-GR mRNA co-injected xCEP290 morphant with or without the DEX treatment. Upper left panel : control-MO with the DEX treatment, lower left panel : xCEP290-MO with the DEX treatment, upper middle panel : xCEP290-MO with EnR-xFOSL1-GR mRNA (100 pg), and lower middle panel : xCEP290-MO with EnR-xFOSL1-GR mRNA (100 pg) and the DEX treatment. Enlarged images from the upper and lower middle panels are also shown. Edemas are indicated by white arrows . The scale bar represents 1 mm. J , the percentage of embryos with edema in examined embryos in ( I ). Each ‘n’ indicates the total number of embryos from three independent experiments. K , pronephric tubule was visualized by FITC-ECL staining ( green ). Upper left panel : control-MO with the DEX treatment, lower left panel : xCEP290-MO with the DEX treatment, upper right panel : xCEP290-MO with EnR-xFOSL1-GR mRNA (100 pg), and lower right panel : xCEP290-MO with EnR-xFOSL1-GR mRNA (100 pg) with the DEX treatment. The scale bar represents 50 μm. L , quantification of pronephric tubular inner diameter of in examined embryos in ( K ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗ indicates p < 0.0001. M , the expression level of xMMP1 gene induced by overexpression of xFOSL1 in kidney by RT-qPCR. Expressions of genes were normalized with xODC1 gene expression, and expressions in control groups were set as 1. Each data point represents the mean ± STDEV of three independent experiments were performed. ∗: p < 0.05.

    Article Snippet: Following three washes in PBT, embryos were incubated with 10% goat serum in PBT at room temperature for 1 h. Then incubated at 4 o C overnight with the following primary antibodies: mouse acetylated- α -tubulin antibody (Sigma-Aldrich, T6793, 1/100), FITC-ECL (Vector Laboratories, FL-1141, 1/100) and rabbit anti-phosphorylated-xSTAT3 (p-STAT3: Tyr705) (Cell Signaling, 9145, 1/200).

    Techniques: Control, RNA Sequencing, Quantitative RT-PCR, Injection, Dissection, Gene Expression, Binding Assay, Staining, Expressing, Over Expression

    xCEP290-depletion produced edema and dilated pronephric tubule in Xenopus embryo . A , the edema formation observed in x CEP290 morphant. Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (10 ng), lower left panel : xCEP290-MO (20 ng), and lower right panel : xCEP290-MO (40 ng). A typical edema in each panel is indicated by a white arrow . The scale bar represents 1 mm. B , the percentage of embryos with edema in examined embryos in ( A ). Each ‘n’ indicates the total number of embryos from three independent experiments. C , the schematic showing Xenopus pronephric tubular segmentated patterns . Each color represents coelomic cavity ( flesh color ), glomerulus/glomus ( red ), proximal tubule ( yellow green ), distal tubule ( purple ) and collecting tubule ( blue ). Proximal and distal pronephric tubules are stained by FITC-conjugated Erythrina crista-galli lectin (FITC-ECL: green ) at stage 37. Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (10 ng), lower left panel : xCEP290-MO (20 ng), and lower right panel : xCEP290-MO (40 ng). A typical expanded inner diameter of pronephric tubule is indicated by a white arrow in the lower right panel . The scale bar represents 50 μm. D , quantification of inner diameter in pronephric tubule of examined embryo in ( C ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗: p < 0.0001. E , edema formation in xCEP290 morphant with or without co-injection of hCEP290 mRNA. Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (40 ng), lower left panel : control-MO (40 ng) with hCEP290 mRNA (500 pg), and lower right panel : xCEP290-MO (40 ng) with hCEP290 mRNA (500 pg). Edemas are indicated by white arrows in the upper right panel . The scale bar represents 1 mm. F , the percentage of embryos with edema in examined embryos in ( E ). Each ‘n’ indicates the total number of embryos from three independent experiments. G , pronephric tubule was visualized using FITC-ECL staining ( green ). Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (40 ng), lower left panel : control-MO (40 ng) with hCEP290 mRNA (500 pg), and lower right panel : xCEP290-MO (40 ng) with hCEP290 mRNA (500 pg). The scale bar represents 50 μm. H , quantification of inner diameter in pronephric tubule of examined embryo in ( G ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗: p < 0.0001.

    Journal: The Journal of Biological Chemistry

    Article Title: Aberrant activation of IL-6/JAK/STAT3/FOSL1 signaling induces renal abnormalities in a Xenopus model of Joubert syndrome-related disorders

    doi: 10.1016/j.jbc.2025.110413

    Figure Lengend Snippet: xCEP290-depletion produced edema and dilated pronephric tubule in Xenopus embryo . A , the edema formation observed in x CEP290 morphant. Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (10 ng), lower left panel : xCEP290-MO (20 ng), and lower right panel : xCEP290-MO (40 ng). A typical edema in each panel is indicated by a white arrow . The scale bar represents 1 mm. B , the percentage of embryos with edema in examined embryos in ( A ). Each ‘n’ indicates the total number of embryos from three independent experiments. C , the schematic showing Xenopus pronephric tubular segmentated patterns . Each color represents coelomic cavity ( flesh color ), glomerulus/glomus ( red ), proximal tubule ( yellow green ), distal tubule ( purple ) and collecting tubule ( blue ). Proximal and distal pronephric tubules are stained by FITC-conjugated Erythrina crista-galli lectin (FITC-ECL: green ) at stage 37. Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (10 ng), lower left panel : xCEP290-MO (20 ng), and lower right panel : xCEP290-MO (40 ng). A typical expanded inner diameter of pronephric tubule is indicated by a white arrow in the lower right panel . The scale bar represents 50 μm. D , quantification of inner diameter in pronephric tubule of examined embryo in ( C ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗: p < 0.0001. E , edema formation in xCEP290 morphant with or without co-injection of hCEP290 mRNA. Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (40 ng), lower left panel : control-MO (40 ng) with hCEP290 mRNA (500 pg), and lower right panel : xCEP290-MO (40 ng) with hCEP290 mRNA (500 pg). Edemas are indicated by white arrows in the upper right panel . The scale bar represents 1 mm. F , the percentage of embryos with edema in examined embryos in ( E ). Each ‘n’ indicates the total number of embryos from three independent experiments. G , pronephric tubule was visualized using FITC-ECL staining ( green ). Upper left panel : control-MO (40 ng), upper right panel : xCEP290-MO (40 ng), lower left panel : control-MO (40 ng) with hCEP290 mRNA (500 pg), and lower right panel : xCEP290-MO (40 ng) with hCEP290 mRNA (500 pg). The scale bar represents 50 μm. H , quantification of inner diameter in pronephric tubule of examined embryo in ( G ). Each ‘n’ indicates the total number of embryos from three independent experiments. ∗∗∗∗: p < 0.0001.

    Article Snippet: After treating with 0.1% Triton X-100 and 0.2% BSA in PBS (PBT), the embryos were incubated with 10% goat serum in PBT at room temperature for 1 h, followed by incubation with FITC-conjugated E . crist-agall i lectin (FITC-ECL: Vector Laboratories, FL-1141, 1/100) at 4 °C overnight.

    Techniques: Produced, Control, Staining, Injection